Metabolomic and proteomic analyses for pharmacotherapy

• In: C3 - Evolution of pharmaceutical care by molecular diagnosis at genome and post-genome era on Monday, 30 August 2010, 14:00-17:00
• At: Lisbon (Portugal) (2010)
• Type: Presentation
• By: TANIGAWARA, Yusuke (Keio University, School of Medicine, Tokyo, Japan)
• Abstract:

  The individualization of pharmacotherapy based on each patient's responsiveness to drugs is required to improve clinical outcome, particularly for life-threatening cancer chemotherapy. We have studied exploratory genomic, proteomic and metabolomic analyses to discover potential biomarkers that can predict responders/non-responders to cancer

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login